Thymic epithelial neoplasm
MONDO:0018079An epithelial neoplasm that affects the thymus gland. This category includes thymomas and carcinomas.
Also known as: TEN, Thymus epithelial neoplasm, Thymus epithelial tumor, Thymus epithelial tumour, epithelial neoplasm of Thymus, epithelial neoplasm of the Thymus, epithelial tumor of Thymus, epithelial tumor of the Thymus
1628 clinical trials for this condition and its sub-types, 14 tagged with Thymic epithelial neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Thymic epithelial neoplasm
-
Thymoma 44 trials
8 sub-types
- Invasive malignant thymoma 4 trials
- Thymoma type B 0 trials · 4 incl. sub-types Sub-types →
- Combined thymoma 0 trials
- Encapsulated thymoma 0 trials
- Noninvasive malignant thymoma 0 trials
- Thymoma type A 0 trials Sub-types →
- Thymoma type AB 0 trials Sub-types →
- Thymoma, familial 0 trials
-
Thymic carcinoma 41 trials · 44 incl. sub-types
9 sub-types
- Invasive malignant thymoma 4 trials
- Thymic neuroendocrine carcinoma 3 trials Sub-types →
- Lymphoepithelioma-like thymic carcinoma 0 trials
- Malignant type AB thymoma 0 trials
- Thymic sarcomatoid carcinoma 0 trials
- Thymic undifferentiated carcinoma 0 trials
- Thymus clear cell carcinoma 0 trials
- Thymus gland adenocarcinoma 0 trials Sub-types →
- Thymus squamous cell carcinoma 0 trials Sub-types →
Most studied deeper sub-types
-
New hope for rare thymus cancers: PT-112 trial launches
Disease control Recruiting nowThis study tests a drug called PT-112 in people with thymoma or thymic cancer that has come back or worsened after standard treatment. PT-112 is designed to kill cancer cells and boost the immune system. About 53 adults will receive the drug intravenously in 28-day cycles. The ma…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Shorter radiation after thymic tumor surgery may cut side effects
Disease control Recruiting nowThis study tests a shorter, higher-dose-per-day radiation schedule (hypofractionated radiotherapy) given after complete surgical removal of stage II or III thymic epithelial tumors. The goal is to see if this approach is safe and tolerable, while also checking how well it control…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Immune cells engineered to hunt thymus cancer show promise in early trial
Disease control Recruiting nowThis study tests whether specially engineered immune cells (CAR-NK cells) can safely treat people with advanced thymus cancers that have not responded to other treatments. Participants will receive cells that target one of three proteins found on their tumor. The goal is to find …
Phase 1/2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Scientists collect tissue to unlock lung cancer secrets
Knowledge-focused Recruiting nowThis study collects tissue samples and health information from 2000 adults with certain lung and thymic cancers. Researchers aim to better understand these diseases, which could lead to new diagnostic tools and treatments. Participants provide blood, tumor samples, and imaging da…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New radiation technique aims to protect heart in thoracic cancer patients
Knowledge-focused Recruiting nowThis study tests whether a newer, MRI-guided radiation method (MRgART) is gentler on the heart than standard radiation (LINAC) for people with lung, esophageal, or other chest cancers. About 60 adults will receive radiation and have their heart function checked via MRI and blood …
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists dive deep into thymic tumors to unlock new clues
Knowledge-focused Recruiting nowThis study looks at thymic epithelial tumors, a rare type of cancer in the chest. Researchers will collect tumor and blood samples from 50 patients during surgery to analyze the immune cells and genetic changes in the tumors. The goal is to better understand the disease and ident…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC